When the COVID-19 pandemic first started, no effective anti-viral drugs were available to fight the disease. However, in record time, so-called monoclonal antibodies were developed as a lifesaving ...

Mucosal Vaccine Delivery Systems: The Future of Immunization (Part 1) is a new release from Bentham Science that delivers a comprehensive exploration of mucosal immunization strategies, offering fresh ...

Rapid shift toward patient-administered intranasal therapies and advanced drug-device integration accelerates global market expansion NEWARK, DE / ACCESS Newswire / March 17, 2026 / The global nasal ...

Novel findings from a preclinical head-to-head comparison show that administering a COVID-19 vaccine as a nasal spray rather than a subcutaneous injection enhances the body's long-term immune memory, ...

The global COVID-19 vaccination campaign saved an estimated 20 million lives. However, while current COVID-19 vaccines provide protection against developing severe disease, they do little to prevent ...

A team of scientists, led by Duke-NUS Medical School, has discovered a potential intranasal vaccine candidate that provides improved, longer-lasting immunity against SARS-CoV-2 viruses compared to ...

Ethris and Lonza agreed to collaborate on the development of room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates, designed for mucosal delivery to combat respiratory ...